FDA recall, , Moderate risk
Vitalant Apheresis Platelets, Leukocytes Reduced
Apheresis Platelets, Leukocytes Reduced were distributed with platelet yield that did not meet specifications.
Recall ended Aug 28, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
Vitalant recalled Apheresis Platelets, Leukocytes Reduced, distributed in Colorado, because the platelet yield did not meet specifications. The company began the recall on November 8, 2025. The FDA added the recall to its Enforcement Report on August 28, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Platelets, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- Vitalant
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99429
- Recall number
- B-0189-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
